MEDROXYPROGESTERONE acetate, 150mg, 1ml, vial
STD
DINJMEDR1V-
Valid Article
Account code:
60000
HS Code:
300439
Last Updated on:
11/12/2024, 19:08:51
Former
Code(s):
-X
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
G03AC06
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
MEDROXYPROGESTERONE 150mg
Full Name
Synonym: depot medroxyprogesterone acetate (DMPA) or Depo-Provera®
Therapeutic Action
Long-acting synthetic progestogen
Indications
Long-acting female contraception (3 months)
Long-term treatment of functional uterine bleeding
Instructions for use
Must be given as deep IM injection every 3 months.
Shake the vial well before administration to make the injectable suspension homogeneous.
Precautions for Use
Contraindicated during pregnancy.
Storage
- Below 25ºC
- Do not refrigerate. Do not freeze.